Literature DB >> 21278395

Peripheral neuropathy as an adverse effect of imatinib therapy.

Geothy Chakupurakal, Roland J O Etti, Jim A Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278395     DOI: 10.1136/jcp.2010.085936

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour.

Authors:  Sonia Kumari; Jennifer M Sherriff; David Spooner; Robert Beckett
Journal:  BMJ Case Rep       Date:  2013-04-05

Review 2.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

3.  Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.

Authors:  Takashi Ishida; Naoyuki Akagawa; Tomomi Miyata; Naomi Tominaga; Takahiro Iizuka; Masaaki Higashihara; Takahiro Suzuki; Koji Miyazaki
Journal:  Int J Hematol       Date:  2017-10-13       Impact factor: 2.490

4.  A case of herpes zoster peripheral polyneuropathy manifested by foot drop in chronic myeloid leukemia.

Authors:  Dong Hyuk Seo; Seong Jae Lee; Jung Keun Hyun; Tae Uk Kim
Journal:  Ann Rehabil Med       Date:  2012-10-31

5.  Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia.

Authors:  Simon Kavanagh; Vera Bril; Jeffrey H Lipton
Journal:  Blood Res       Date:  2018-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.